Table 1.
Comparison of baseline characteristics between patients who did and did not develop osteoporosis
| No osteoporosis (n=155) |
Osteoporosis (n=39) |
P-value | |
|---|---|---|---|
| Age (years) | 60.9±0.6 | 61.2±1.2 | 0.37 |
| BMI (kg/m2) | 28.3±6.4 | 27.6±5.1 | 0.49 |
| Hypertension (%) | 49.3 | 59.0 | 0.28 |
| Diabetes (%) | 5.8 | 5.1 | 0.87 |
| Hyperlipidemia (%) | 60.5 | 71.7 | 0.19 |
| History of vascular disease (%) | 7.7 | 7.9 | 0.97 |
| Ejection fraction (%) | 61.1±1.5 | 61.4±3.6 | 0.94 |
| Hemoglobin A1c (%) | 5.54±0.07 | 5.54±0.15 | 0.96 |
| Glucose (mg/dL) | 100.9±2.3 | 98.0±4.6 | 0.58 |
| Medication use (%) | |||
| Beta blocker | 20.5 | 13.5 | 0.28 |
| Antiarrhythmic | 1.03 | 8.4 | 0.50 |
| Aspirin | 48.7 | 46.4 | 0.8 |
| Multivitamin use | 54.5 | 20.5 | 0.60 |
| Antihypertensive use | 22.5 | 23.1 | 0.95 |
| Calcium channel blocker | 37.4 | 38.5 | 0.90 |
| Digitalis | 3.2 | 2.6 | 0.83 |
| Estrogen | 41.3 | 38.4 | 0.75 |
| Lipid lowering drug | 40.6 | 35.9 | 0.59 |
| Anticoagulant | 11.0 | 13.2 | 0.70 |
| Oral hypoglycemic | 3.2 | 5.1 | 0.57 |
| Insulin | 0.6 | 2.6 | 0.29 |
| Steroid | 2.6 | 5.1 | 0.41 |
Abbreviation: BMI, body mass index.